These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 8202520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
    Izaguirre G, Olson ST.
    J Biol Chem; 2006 May 12; 281(19):13424-13432. PubMed ID: 16517611
    [Abstract] [Full Text] [Related]

  • 9. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.
    Li CQ, Vindigni A, Sadler JE, Wardell MR.
    J Biol Chem; 2001 Mar 02; 276(9):6161-8. PubMed ID: 11024046
    [Abstract] [Full Text] [Related]

  • 10. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex.
    Fredenburgh JC, Stafford AR, Leslie BA, Weitz JI.
    J Biol Chem; 2008 Feb 01; 283(5):2470-7. PubMed ID: 18055456
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thrombin specificity.
    Guillin MC, Bezeaud A, Bouton MC, Jandrot-Perrus M.
    Thromb Haemost; 1995 Jul 01; 74(1):129-33. PubMed ID: 8578445
    [Abstract] [Full Text] [Related]

  • 16. Molecular mapping of the thrombin-heparin cofactor II complex.
    Fortenberry YM, Whinna HC, Gentry HR, Myles T, Leung LL, Church FC.
    J Biol Chem; 2004 Oct 08; 279(41):43237-44. PubMed ID: 15292227
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST, Rezaie AR, Esmon CT, Church FC.
    Thromb Res; 2002 Jul 15; 107(1-2):67-73. PubMed ID: 12413592
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of dysthrombins Quick I and II by heparin cofactor II and antithrombin.
    Phillips JE, Shirk RA, Whinna HC, Henriksen RA, Church FC.
    J Biol Chem; 1993 Feb 15; 268(5):3321-7. PubMed ID: 8429008
    [Abstract] [Full Text] [Related]

  • 19. Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III.
    Kridel SJ, Chan WW, Knauer DJ.
    J Biol Chem; 1996 Aug 23; 271(34):20935-41. PubMed ID: 8702852
    [Abstract] [Full Text] [Related]

  • 20. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
    Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP.
    BMC Biochem; 2013 Mar 07; 14():6. PubMed ID: 23496873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.